Milestone Scientific (MLSS) vs Regentis Biomaterials (RGNT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Milestone Scientific is the larger company by market cap ($32.6 million vs $11.9 million), about 2.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MLSS | RGNT |
|---|---|---|
| Share price | $0.36 | $1.70 |
| Market cap | $32.62M | $11.94M |
| 1-day change | -2.70% | +4.29% |
| YTD return | +37.04% | -75.82% |
| 1-year return | -17.78% | — |
| 5-year return | -82.46% | — |
| EPS (TTM) | $-0.04 | $-2.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $0.60 | $15.50 |
| 52-week low | $0.22 | $1.23 |
| Distance from 52-week high | -40.00% | -89.03% |
| Average volume | 130.80K | 75.26K |
| Shares outstanding | 90.61M | 7.02M |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Milestone Scientific is about 2.7 times larger than Regentis Biomaterials by market value ($32.62M vs $11.94M).
MLSS vs RGNT FAQ
Which is bigger, Milestone Scientific or Regentis Biomaterials?
Milestone Scientific (MLSS) is larger, with a market capitalization of $32.62M compared with $11.94M for Regentis Biomaterials (RGNT).
Are Milestone Scientific and Regentis Biomaterials in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.